AAPS PharmSciTech

, Volume 19, Issue 8, pp 3343–3354 | Cite as

Industrial Development of a 3D-Printed Nutraceutical Delivery Platform in the Form of a Multicompartment HPC Capsule

  • Alice Melocchi
  • Federico Parietti
  • Simone Maccagnan
  • Marco Aldo Ortenzi
  • Stefano Antenucci
  • Francesco Briatico-Vangosa
  • Alessandra MaroniEmail author
  • Andrea Gazzaniga
  • Lucia Zema
Research Article Theme: Printing and Additive Manufacturing
Part of the following topical collections:
  1. Theme: Printing and Additive Manufacturing


Following recent advances in nutrigenomics and nutrigenetics, as well as in view of the increasing use of nutraceuticals in combination with drug treatments, considerable attention is being directed to the composition, bioefficacy, and release performance of dietary supplements. Moreover, the interest in the possibility of having such products tailored to meet specific needs is fast growing among costumers. To fulfill these emerging market trends, 3D-printed capsular devices originally intended for conveyance and administration of drugs were proposed for delivery of dietary supplements. Being composed of separate inner compartments, such a device could yield customized combinations of substances, relevant doses, and release kinetics. In particular, the aim of this work was to face early-stage industrial development of the processes involved in fabrication of nutraceutical capsules for oral pulsatile delivery. A pilot plant for extrusion of filaments based on pharmaceutical-grade polymers and intended for 3D printing was set up, and studies aimed at demonstrating feasibility of fused deposition modeling in 3D printing of capsule shells according to Current Good Manufacturing Practices for dietary supplements were undertaken. In this respect, the stability of the starting material after hot processing and of the resulting items was investigated, and compliance of elemental and microbiological contaminants, as well as of by-products, with internal specifications was assessed. Finally, operating charts highlighting critical process variables and parameters that would serve as indices of both intermediate and final product quality were developed.


fused deposition modeling microextrusion capsular device pulsatile release caffeine 


  1. 1.
    Gazzaniga A, Cerea M, Cozzi A, Foppoli A, Maroni A, Zema L. A novel injection-molded capsular device for oral pulsatile delivery based on swellable/erodible polymers. AAPS PharmSciTech. 2011;12:295–303.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Zema L, Loreti G, Macchi E, Foppoli A, Maroni A, Gazzaniga A. Injection-molded capsular device for oral pulsatile release: development of a novel mold. J Pharm Sci. 2013;102:489–99.CrossRefPubMedGoogle Scholar
  3. 3.
    Zema L, Loreti G, Melocchi A, Maroni A, Palugan L, Gazzaniga A. Gastroresistant capsular device prepared by injection molding. Int J Pharm. 2013;440:264–72.CrossRefPubMedGoogle Scholar
  4. 4.
    Melocchi A, Parietti F, Loreti G, Maroni A, Gazzaniga A, Zema L. 3D printing by fused deposition modeling (FDM) of a swellable/erodible capsular device for oral pulsatile release of drugs. J Drug Deliv Sci Technol. 2015;30 Part B:360–7.CrossRefGoogle Scholar
  5. 5.
    Maroni A, Melocchi A, Parietti F, Foppoli A, Zema L, Gazzaniga A. 3D printed multi-compartment capsular devices for two-pulse oral drug delivery. J Control Release. 2017;268:10–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Melocchi A, Parietti F, Maroni A, Foppoli A, Gazzaniga A, Zema L. Hot-melt extruded filaments based on pharma-grade polymers for 3D printing by fused deposition modeling. Int J Pharm. 2016;509:255–63.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Zema L, Loreti G, Melocchi A, Maroni A, Gazzaniga A. Injection molding and its application to drug delivery. J Control Release. 2012;159:324–31.CrossRefPubMedGoogle Scholar
  8. 8.
    Zema L, Melocchi A, Maroni A, Gazzaniga A. 3D printing of medicinal products and the challenge of personalized medicine. J Pharm Sci. 2017;106:1697–705.CrossRefPubMedGoogle Scholar
  9. 9.
    Sun Y, Soh S. Printing tablets with fully customizable release profiles for personalized medicine. Adv Mater. 2015;27:7847–53.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Kussmann M, Fay LB. Nutrigenomics and personalized nutrition: science and concept. Pers Med. 2008;5:447–55.CrossRefGoogle Scholar
  11. 11.
    Eussen SRBM, Verhagen H, Klungel OH, Garssen J, van Loveren H, van Kranen HJ, et al. Functional foods and dietary supplements: products at the interface between pharma and nutrition. Eur J Pharmacology. 2011;668:S2–9.CrossRefGoogle Scholar
  12. 12.
    Ostan R, Béné MC, Spazzafumo L, Pinto A, Donini LM, Pryen F, et al. Impact of diet and nutraceutical supplementation on inflammation in elderly people. Results from the RISTOMED study, an open-label randomized control trial. Clin Nutr. 2016;35:812–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Braithwaite MC, Tyagi C, Tomar LK, Kumar P, Choonara YE, Pillay V. Nutraceutical-based therapeutics and formulation strategies augmenting their efficiency to complement modern medicine: an overview. J Funct Foods. 2014;6:82–9.CrossRefGoogle Scholar
  14. 14.
    Ting Y, Jiang Y, Ho C-T, Huang Q. Common delivery systems for enhancing in vivo bioavailability and biological efficacy of nutraceuticals. J Funt Foods. 2014;7:112–28.CrossRefGoogle Scholar
  15. 15.
    Gazzaniga A, Busetti C, Moro L, Sangalli ME, Giordano F. Time-dependent oral delivery systems for colon-targeting. STP Pharma. 1995;5:83–8.Google Scholar
  16. 16.
  17. 17.
    Prodduturi S, Manek RV, Kolling WM, Stodghill SP, Repka MA. Water vapor sorption of hot-melt extruded hydroxypropyl cellulose films: effect on physico-mechanical properties, release characteristics, and stability. J Pharm Sci. 2004;93:3047–56.CrossRefPubMedGoogle Scholar
  18. 18.
    Sarode AL, Malekar SA, Cote C, Worthen DR. Hydroxypropyl cellulose stabilizes amorphous solid dispersions of the poorly water soluble drug felodipine. Carbohydr Polym. 2014;112:512–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Loreti G, Maroni A, Del Curto MD, Melocchi A, Gazzaniga A, Zema L. Evaluation of hot-melt extrusion technique in the preparation of HPC matrices for prolonged release. Eur J Pharm Sci. 2014;52:77–85.CrossRefPubMedGoogle Scholar
  20. 20.
  21. 21.
    Wittgren B, Porsch P. Molar mass distribution of hydroxypropyl cellulose by size exclusion chromatography with dual light scattering and refractometric detection. Carbohydr Polym. 2002;49:457–69.CrossRefGoogle Scholar
  22. 22.
    Perale G, Giordano C, Daniele F, Tunesi M, Colombo P, Gottardo L, et al. Extruded ceramic microelectrodes for biomedical applications. Int J Artif Organs. 2008;31:272–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Perale G, Pertici G, Giordano C, Daniele F, Masi M, Maccagnan S. Nondegradative microextrusion of resorbable polyesters for pharmaceutical and biomedical applications: the cases of poly-lactic-acid and poly-caprolactone. J Appl Polym Sci. 2008;108:1591–5.CrossRefGoogle Scholar
  24. 24.
    Perale G, Arosio P, Moscatelli D, Barri V, Müller M, Maccagnan S, et al. A new model of resorbable device degradation and drug release: transient 1-dimension diffusional model. J Control Release. 2009;136:196–205.CrossRefPubMedGoogle Scholar
  25. 25.
    Perale G, Casalini T, Barri V, Mueller M, Maccagnan S, Masi M. Lidocaine release from polycaprolactone threads. J Appl Polym Sci. 2010;117:3610–4.Google Scholar
  26. 26.
    Pertici G, Maccagnan S, Müller M, Rossi F, Daniele F, Tunesi M, et al. Porous biodegradable microtubes-based scaffolds for tissue engineering, part I: production and preliminary in vitro evaluation. J Appl Biomater Biomech. 2008;6:186–92.PubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  • Alice Melocchi
    • 1
    • 2
  • Federico Parietti
    • 2
  • Simone Maccagnan
    • 3
  • Marco Aldo Ortenzi
    • 4
    • 5
  • Stefano Antenucci
    • 4
    • 5
  • Francesco Briatico-Vangosa
    • 6
  • Alessandra Maroni
    • 1
    Email author
  • Andrea Gazzaniga
    • 1
  • Lucia Zema
    • 1
  1. 1.Dipartimento di Scienze Farmaceutiche, Sezione di Tecnologia e Legislazione Farmaceutiche “Maria Edvige Sangalli”Università degli Studi di MilanoMilanItaly
  2. 2.Multiply LabsSan FranciscoUSA
  3. 3.GimacCastronnoItaly
  4. 4.Dipartimento di ChimicaUniversità degli Studi di MilanoMilanItaly
  5. 5.LamPo, Dipartimento di ChimicaUniversità degli Studi di MilanoMilanItaly
  6. 6.Dipartimento di Chimica, Materiali e Ingegneria Chimica “G. Natta”Politecnico di MilanoMilanItaly

Personalised recommendations